Kawasaki Disease: Beyond IVIG and Aspirin
- 1 October 2019
- journal article
- research article
- Published by SLACK, Inc. in Pediatric Annals
- Vol. 48 (10) , e400-e405
Abstract
Kawasaki disease (KD) is a vasculitis syndrome of unknown etiology, affecting medium-sized vessels and occurring primarily in young children. It is a self-limited illness classically presenting with fever, conjunctivitis, mucocutaneous lesions, and cervical adenopathy. However, vasculitis of coronary arteries with aneurysm formation may occur, leading to morbidity and rarely mortality. Prompt diagnosis of KD is essential as early treatment with intravenous immune globulin (IVIG) decreases the occurrence and severity of coronary vasculitis. This article reviews the clinical characteristics of KD, laboratory assessment, echocardiogram findings, and recommended initial medical therapy. Complications of KD are discussed, including KD refractory to IVIG, the presence of shock or macrophage activation syndrome (MAS), and short/long-term cardiac sequelae. The medical management of these complications is reviewed. Although improved treatment of KD has resulted in a decrease of coronary artery vasculitis over the past 3 decades, KD remains the most common cause of acquired heart disease in children. [ Pediatr Ann. 2019;48(10):e400–e405.]Keywords
This publication has 24 references indexed in Scilit:
- Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart AssociationCirculation, 2017
- Coronary Artery Aneurysms in Kawasaki Disease: Risk Factors for Progressive Disease and Adverse Cardiac Events in the US PopulationJournal of the American Heart Association, 2016
- Three Linked Vasculopathic Processes Characterize Kawasaki Disease: A Light and Transmission Electron Microscopic StudyPLOS ONE, 2012
- Hospitalizations for Kawasaki Syndrome Among Children in the United States, 1997–2007The Pediatric Infectious Disease Journal, 2010
- Improved Classification of Coronary Artery Abnormalities Based Only on Coronary Artery z-Scores After Kawasaki DiseasePediatric Cardiology, 2009
- Risk factors for Kawasaki disease-associated coronary abnormalities differ depending on ageEuropean Journal of Pediatrics, 2009
- EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitidesAnnals of the Rheumatic Diseases, 2006
- Incidence of Henoch-Schonlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic originsThe Lancet, 2002
- A Single Intravenous Infusion of Gamma Globulin as Compared with Four Infusions in the Treatment of Acute Kawasaki SyndromeNew England Journal of Medicine, 1991
- The Treatment of Kawasaki Syndrome with Intravenous Gamma GlobulinNew England Journal of Medicine, 1986